Ampio Pharmaceuticals, Inc. (33)

Browse by Contract Category

Contracts

Amendment No. 1 to Employment Agreement dated August 30, 2022 by and between Ampio Pharmaceuticals, Inc. and Michael A. Martino (Filed With SEC on September 1, 2022)
Personal Services Agreement between the Registrant and Dr. Bar-Or, dated February 4, 2022 (Filed With SEC on May 16, 2022)
Specimen Common Stock Certificate of the Registrant (Filed With SEC on March 29, 2022)
Placement Agent Agreement, dated December 13, 2021, by and between Ampio Pharmaceuticals, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on December 15, 2021)
Research Services Agreement between the Registrant and Trauma Research LLC, dated February 4, 2022 (Filed With SEC on May 16, 2022)
Form of Indemnification Agreement between Ampio Pharmaceuticals, Inc. and certain directors, executive officers and key employees (Filed With SEC on March 29, 2022)
Employment Agreement between Ampio Pharmaceuticals, Inc. and Daniel Stokely, dated October 11, 2021 (Filed With SEC on March 29, 2022)
Employment Agreement by and between Ampio Pharmaceuticals, Inc. and Holli Cherevka, dated October 11, 2021 (Filed With SEC on March 29, 2022)
Employment Agreement by and between Ampio Pharmaceuticals, Inc. and Michael Macaluso, dated October 11, 2021 (Filed With SEC on March 29, 2022)
2019 Stock Incentive Plan and forms of option agreements (Filed With SEC on March 29, 2022)
Form of Securities Purchase Agreement (Filed With SEC on December 15, 2021)
Form of Warrant (Filed With SEC on December 15, 2021)
Employment Agreement, by and between Ampio Pharmaceuticals, Inc. and Michael Martino, dated November 22, 2021 (Filed With SEC on November 29, 2021)
Specimen Common Stock Certificate of the Registrant (Filed With SEC on March 3, 2021)
2019 Stock Incentive Plan and forms of option agreements (Filed With SEC on March 3, 2021)
Amendment No. 3 to Employment Agreement, dated July 13, 2020, between the Company and Daniel Stokely (Filed With SEC on July 14, 2020)
Loan Agreement, dated April 16, 2020, by and between Key Bank National Association and Ampio Pharmaceuticals, Inc (Filed With SEC on April 22, 2020)
Amendment No. 3 to Human Serum Albumin Ingredient Purchase and Sale Agreement among Ampio Pharmaceuticals, Inc., Octapharma USA, Inc. and Nova Biologics, Inc., effective as of... (Filed With SEC on February 21, 2020)
Description of Capital Stock of Ampio Pharmaceuticals, Inc (Filed With SEC on February 21, 2020)
Sales Agreement, dated as of February 20, 2020, by and among ThinkEquity, a division of Fordham Financial Management, Inc., Roth Capital Partners LLC and Ampio Pharmaceuticals, Inc (Filed With SEC on February 20, 2020)
Employment Agreement, dated December 14, 2019, between the Company and Michael Macaluso (Filed With SEC on December 18, 2019)
Amendment No. 2 to Employment Agreement, dated December 14, 2019, between the Company and Daniel Stokely (Filed With SEC on December 18, 2019)
Amendment to Cancellation Agreement, dated November 7, 2019, between Ampio Pharmaceuticals Inc. and Daniel Stokely (Filed With SEC on November 7, 2019)
Form of Warrant Exercise Agreement (Filed With SEC on October 29, 2019)
Employment Agreement, dated September 16, 2019, between the Company and Holli Cherevka (Filed With SEC on September 20, 2019)
Stock Option Cancellation and Grant Agreement for Executive, dated August 20, 2019, between the Company and Daniel Stokely (Filed With SEC on August 23, 2019)
Amendment to Employment Agreement, dated August 20, 2019, between the Company and Daniel Stokely (Filed With SEC on August 23, 2019)
Employment Agreement, dated July 9, 2019, between the Company and Daniel Stokely (Filed With SEC on July 10, 2019)
Placement Agency Agreement, dated June 17, 2019, by and among Ampio Pharmaceuticals, Inc. and ThinkEquity, a division of Fordham Financial Management, Inc (Filed With SEC on June 17, 2019)
Form of Lock-Up Agreement (Filed With SEC on June 17, 2019)
Form of Securities Purchase Agreement (Filed With SEC on June 17, 2019)
Separation Agreement, dated as of June 13, 2019, between Ampio Pharmaceuticals, Inc. and Thomas E. Chilcott, III (Filed With SEC on June 13, 2019)
Equity Distribution Agreement, dated as of April 12, 2019, by and between Canaccord Genuity LLC and Ampio Pharmaceuticals, Inc (Filed With SEC on April 15, 2019)